Many of the pathways CK1 participates in are deregulated in PCa; moreover, transcriptomic data suggest that CSNK1A1 is more highly expressed in PCa as compared to precursor conditions such as benign prostatic hyperplasia. Here, CSNK1A1 is linked to benign prostatic hyperplasia.